The analysts expect Pfizer to report an fourth quarter EPS loss of $(0.22) and revenues of $14.25 billion.
For FY24, Pfizer expects revenue of $58.5 billion-$61.5 billion, including the expected contribution from Seagen.
For FY24, Pfizer expects revenue of $58.5 billion-$61.5 billion, including the expected contribution from Seagen.
Category
🗞
NewsTranscript
00:00 [Music]
00:02 [Music]
00:04 [Music]
00:07 [Music]
00:09 [Music]
00:36 [Music]
01:03 [Music]